Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis.
Mult Scler
; 27(10): 1564-1576, 2021 09.
Article
in En
| MEDLINE
| ID: mdl-33205682
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Azetidines
/
Benzyl Compounds
/
Multiple Sclerosis, Chronic Progressive
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Mult Scler
Journal subject:
NEUROLOGIA
Year:
2021
Type:
Article
Affiliation country:
United States